Dual cellular targeting of complement receptor 2 (CR2/CD21) synergistically suppresses autoreactive germinal center activity and autoimmunity in lupus
Pathogenic germinal center (GC) activity persists in systemic lupus erythematosus (SLE) because current B cell-targeting therapies do not consistently elim